CoChat

MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells

Shen, Wei-Wei, Zeng, Zhi, Zhu, Wen-Xia, Fu, Guo-Hui · 2013 · Journal of Molecular Medicine

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Studies have shown that the expression of CD133, leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5), and ATP binding cassette (ABC)G2 proteins is associated with malignancy and poor prognosis in colon cancer. However, molecular regulation mechanism of the three proteins has not been elucidated. Here, we report that microRNA-142-3p (miR-142-3p) inhibits the expression of CD133, Lgr5, and ABCG2 in colon cancer cells by binding to both the 3'-untranslated region and the coding sequences of the three genes. The miR-142-3p was markedly decreased in colon cancer specimens, in which it was negatively correlated with the expression of CD133, Lgr5, and ABCG2. Reduction of miR-142-3p corresponds to poor differentiation and bigger tumor size in colon cancers. Moreover, miR-142-3p levels were reduced in cells that formed spheres compared to cells that were cultured in regular media. Transfection of miR-142-3p mimics in colon cancer cells downregulated cyclin D1 expression, induced G1 phase cell cycle arrest, and elevated the sensitivity of the cells to 5-fluorouracil. Furthermore, OCT4 suppressed miR-142-3p, and hypomethylation of the OCT4 promoter was associated with a reduction in miR-142-3p. Finally, the miR-142-3p inhibited the growth of colon cancer cells in vivo, which was accompanied by the downregulation of CD133, Lgr5, and ABCG2 in tumor tissues. Our results elucidate a novel regulation pathway in colon cancer cells and suggest a potential therapeutic approach for colon cancer therapy.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00109-013-1037-x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 142

Metadata

Authors
Shen, W.-W., Zeng, Z., Zhu, W.-X., & Fu, G.-H.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
Fu, Guo-Hui
Venue
Journal of Molecular Medicine
Published
2013-04-26
Volume
91
Issue
8
Pages
989-1000
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W2017927877
Cited by
137
References
33
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 18 · 2020: 8 · 2019: 17 · 2018: 19 · 2017: 11 · 2016: 11 · 2015: 17 · 2014: 7 · 2013: 3
FWCI
4.45
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
miR-142-3p, colon cancer, tumor suppressor microRNA, CD133, ABCG2, Lgr5, Oct4, promoter hypomethylation, 3' untranslated region, cyclin D1, G1 cell cycle arrest, 5-fluorouracil sensitivity, cancer stem cells, tumor growth
MeSH terms
ATP Binding Cassette Transporter, Subfamily G, Member 2, AC133 Antigen, Animals, Antimetabolites, Antineoplastic, Colonic Neoplasms, Female, Fluorouracil, Glycoproteins, Humans, Male, Neoplasm Proteins, Peptides, Antigens, CD, Apoptosis, ATP-Binding Cassette Transporters, Xenograft Model Antitumor Assays, MicroRNAs, Receptors, G-Protein-Coupled, Cell Line, Tumor, Tumor Burden, Octamer Transcription Factor-3, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. https://app.cochat.ai/papers/10.1007/s00109-013-1037-x
The paper
Shen, W.-W., Zeng, Z., Zhu, W.-X., & Fu, G.-H. (2013). MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-013-1037-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.